Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway. | Cell Cycle | 2023 | 37245082 | PubTator, text mining | PubMed |
| Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma. | Discov Oncol | 2023 | 37243813 | PubTator, text mining | PubMed |
| NatB Catalytic Subunit Depletion Disrupts DNA Replication Initiation Leading to Senescence in MEFs. | Int J Mol Sci | 2023 | 37240070 | PubTator, text mining | PubMed |
| Autophagy, innate immunity, and cardiac disease. | Front Cell Dev Biol | 2023 | 37234771 | PubTator, text mining | PubMed |
| Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. | Signal Transduct Target Ther | 2023 | 37221195 | PubTator, text mining | PubMed |
| YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer. | Int J Biol Sci | 2023 | 37215986 | PubTator, text mining | PubMed |
| Methyltransferase Set7/9 as a Multifaceted Regulator of ROS Response. | Int J Biol Sci | 2023 | 37215983 | PubTator, text mining | PubMed |
| A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials. | Front Oncol | 2023 | 37205196 | PubTator, text mining | PubMed |
| Molecular mechanisms involved in regulating protein activity and biological function of MST3. | Cell Div | 2023 | 37202821 | PubTator, text mining | PubMed |
| Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification. | Biomedicines | 2023 | 37189838 | PubTator, text mining | PubMed |
| Exploration and Clinical Verification of the Blood Co-Expression Genes of Type 2 Diabetes Mellitus and Mild Cognitive Dysfunction in the Elderly. | Biomedicines | 2023 | 37189611 | PubTator, text mining | PubMed |
| Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation. | Cell Death Dis | 2023 | 37185904 | PubTator, text mining | PubMed |
| STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment. | Mediators Inflamm | 2023 | 37181807 | PubTator, text mining | PubMed |
| NF2 alteration in mesothelioma. | Front Toxicol | 2023 | 37180489 | PubTator, text mining | PubMed |
| Anomalous Oligomerization Behavior of E. coli Aquaporin Z in Detergent and in Nanodiscs. | Int J Mol Sci | 2023 | 37175807 | PubTator, text mining | PubMed |
| Crosstalk between macrophages and cardiac cells after myocardial infarction. | Cell Commun Signal | 2023 | 37170235 | PubTator, text mining | PubMed |
| Epithelial polarization in the 3D matrix requires MST3 signaling to regulate ZO-1 position. | PLoS One | 2023 | 37155619 | PubTator, text mining | PubMed |
| Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development. | Theranostics | 2023 | 37153735 | PubTator, text mining | PubMed |
| Sperm morphological abnormalities in autosomal dominant polycystic kidney disease are associated with the Hippo signaling pathway via PC1. | Front Endocrinol (Lausanne) | 2023 | 37152951 | PubTator, text mining | PubMed |
| Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis. | Front Mol Biosci | 2023 | 37152902 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=24